The risk of renal disease is increased in lambda myeloma with bone marrow amyloid deposits

about

The risk of renal disease is increased in lambda myeloma with bone marrow amyloid deposits

Item

http://www.wikidata.org/entity/Q37693762

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 06 March 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

The risk of renal disease is i ...... h bone marrow amyloid deposits

@en

The risk of renal disease is i ...... bone marrow amyloid deposits.

@nl

type

Item

label

The risk of renal disease is i ...... h bone marrow amyloid deposits

@en

The risk of renal disease is i ...... bone marrow amyloid deposits.

@nl

prefLabel

The risk of renal disease is i ...... h bone marrow amyloid deposits

@en

The risk of renal disease is i ...... bone marrow amyloid deposits.

@nl

P1476

The risk of renal disease is i ...... h bone marrow amyloid deposits

@en

P2093

Rahel Befekadu

http://www.w3.org/2001/XMLSchema#string

Scott Montgomery

http://www.w3.org/2001/XMLSchema#string

Victoria Hahn-Strömberg

http://www.w3.org/2001/XMLSchema#string

P2860

Poor tolerance to high doses of thalidomide in patients with primary systemic amyloidosis.

Clinical features and treatment response of light chain (AL) amyloidosis diagnosed in patients with previous diagnosis of multiple myeloma

Amyloid deposits in the bone marrow of patients with immunoglobulin light chain amyloidosis do not impact stem cell mobilization or engraftment.

Immunoglobulin light chain variable (V) region genes influence clinical presentation and outcome in light chain-associated amyloidosis (AL).

Primary systemic amyloidosis: clinical and laboratory features in 474 cases.

Review of 1027 patients with newly diagnosed multiple myeloma.

Bone marrow immunohistology of plasma cell neoplasms.

Multiple myeloma-associated AL amyloidosis: is a distinctive therapeutic approach warranted?

Asymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myeloma and smoldering myeloma. A series of 144 cases and a review of the literature.

Amyloid in bone marrow smears of patients affected by multiple myeloma.

P304

29-34

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/JBM.S129516

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Piotr Kozlowski

P577

2017-03-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28293126

http://www.w3.org/2001/XMLSchema#string

P932

5345990

http://www.w3.org/2001/XMLSchema#string